- Have developed new techniques to diagnose the disease in early stages:
Until a few years ago, the only way to confirm that the patient had an excess of TAU protein or amyloid protein in the brain, which are involved in the disease, it was through an autopsy when he had died. Now, on the other hand, have developed techniques that allow you to detect the buildup of these proteins in people who still do not have any symptoms. It is one of the most important advances that have been made in recent years. One of these techniques is to perform neuroimaging tests; that is to make an MRI in patient of all your nervous system, and the other, in the analysis of cerebrospinal fluid, in which liquid is extracted from the lower part of the back part of the brain and which provide information relevant to detect absence, or not, of the protein.
Cerebrospinal fluid |
MRI |